Triple-negative breast cancer (TNBC) represents 15% of breast carcinomas and is defined by the absence of the three main breast cancer biomarkers—estrogen receptors, progesterone receptors, and HER2 (also known as ERBB2) (Denkert et al., 2017). This evidence concerns the gene ERBB2 and breast carcinoma.